Govt Job: Walk in interview for Pharmacist at PGIMER

The PGIMER owes its inception to the vision of late Sardar Partap Singh Kairon, the then Chief Minister of Punjab and the distinguished medical educationists of the then combined state of Punjab, supported by the first Prime Minister of India Pt. Jawahar Lal Nehru who considered the institutions of scientific knowledge as temples of learning and the places of pilgrimage.

Post : Pharmacist

Project Title : A PHASE 2/3, OBSERVER-BLIND, RANDOMIZED, CONTROLLED STUDY TO DETERMINE THE SAFETY AND IMMUNOGENICITY OF COVOVAX [SARS-CoV-2 RECOMBINANT SPIKE PROTEIN NANOPARTICLE VACCINE (SARS- CoV-2 rS) WITH MATRJX-M1 ™ ADJUVANT| IN INDIAN ADULTS AGED > 18 YEARS AND CHILDREN AGED 2 TO 17 YEARS

Qualification : Essential B.Pharma / Diploma in pharmacy from a recognized institution / board, should be a registered pharmacist under the pharmacy act 1948 – Minimum 1 year of experience in dispensing and /or storage and dispensing of drugs in a reputed hospital or institution or in a drug stores of a pharmaceutical concern / Clinical research experience.

Tenure : 3 months

Salary : 33,300/-

Date of Interview : 03rd  September,2021 (Friday)

Time of Interview : 03:00 pm

Selection Process :  An online interview will be conducted on 03ri1 September 2021 at 3:00 PM via zoom/Google meet. In view of C-19, no face to face Interview will be conducted.

How to apply : Interested candidate should email their applications along with their curriculum vitae (softcopy of resume) with supporting documents address to Dr, Madhu Gupta, Professor on email ID : covovax2021@gmail.com

Last date: before 05:00 PM dated 31/08/2021. No applications will be entertained after 05:00 PM on 31/08/2021

Related Posts

4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

Meerut: A four-year-old boy’s condition allegedly worsened after he was administered an anti-rabies injection at Sambhal district hospital following a snakebite. A pharmacist at the hospital has been removed from…

Lupin gets tentative US FDA nod for apixaban oral suspension for patients who cannot swallow tablets

Once final approval comes through, the liquid anticoagulant will be made at Lupin’s plant in Somerset, New Jersey, the company said. Mumbai: Lupin has received tentative approval from the US…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

Delhi High Court sets aside FSSAI order asking Red Bull India to drop ‘energy’ from its drinks

Delhi High Court sets aside FSSAI order asking Red Bull India to drop ‘energy’ from its drinks

Haryana to use Ayushman, Chirayu claim money for hospital staff incentives and upgrades: CM

Haryana to use Ayushman, Chirayu claim money for hospital staff incentives and upgrades: CM

Indian speciality drugs get zero duty as US widens 100% tariff on patented medicines

Indian speciality drugs get zero duty as US widens 100% tariff on patented medicines

Low-dose CT screening lowers lung cancer deaths by 16% in high-risk people: IARC

Low-dose CT screening lowers lung cancer deaths by 16% in high-risk people: IARC

Krsnaa Diagnostics board clears sale of diagnostic equipment worth up to Rs 120 crore

Krsnaa Diagnostics board clears sale of diagnostic equipment worth up to Rs 120 crore